Several case reports of IFN-α treatment during pregnancy in women with CML have been published, and no congenital abnormalities in their infants have been reported (Regierer et al. 2006; Al Bahar et al. 2004). This evidence concerns the gene IFNA1 and chronic myelogenous leukemia, BCR-ABL1 positive.